ZeClinics - Biotechnology CRO - Powering Discovery with Zebrafish ZeClinics - Biotechnology CRO - Powering Discovery with Zebrafish ZeClinics - Biotechnology CRO - Powering Discovery with Zebrafish
  • About us
    • About us overview
    • History & team
    • Mission, vision & values
    • Model
    • Environment
    • Partners
    • Careers
  • Services & Solutions

    BY OUR PLATFORMS

    • ZeTox
    • General Toxicity Assays
    • Fish Embryo Acute Test (FET)
    • Early-life stage toxicity
    • DevTox
    • Endocrine Disruption Assay
    • ReproductionTox
    • Bioavailability Assay
    • Organ-specific Toxicity Assays
    • CardioTox
    • NeuroTox
    • HepatoTox
    • OtoTox
    • ZeGlobalTox
    • ZeGenesis
    • Transgenesis and gene editing services
    • Transgenic lines
    • Knock-out lines
    • F0 knock-out (Crispants)
    • Knock-in lines
    • Transient Knock-down and overexpression approaches
    • Morpholino-based knock-down
    • Antisense oligonucleotides-based knock-down
    • Transient overexpression
    • ZeEfficacy
    • Custom phenotyping
    • Organ-specific assessments
    • High throughput technologies
    • Diet studies
    • Disease models
    • Epilepsy Model
    • Parkinson Disease Model
    • Hearing Loss Model
    • Retinal Degeneration Model
    • Duchenne Muscular Dystrophy(DMD) Model
    • Atherosclerosis Model
    • Non-Alcoholic Fatty Liver Disease (NAFLD) Model
    • Metabolic Disorders and Obesity Model

    BY THERAPEUTIC AREA

    • Otolaryngology
    • Ophthalmology
    • Oncology
    • Metabolic
    • Muscular
    • CNS

    BY RESEARCH STAGE

    • Model Generation
    • Target ID & validation
    • Screening
    • Hit confirmation
    • Hit-to-Lead
    • Tox - ADME
  • Science
  • News
  • Blog
  • Contact